| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |